Coen Steven P.'s Form 4 filing
Ginkgo Bioworks Holdings, Inc. (DNA) · filed May 26, 2026
- Accession no.
- 0001628280-26-038202
- Filed
- May 26, 2026
- Trade date
- May 21-22, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.56K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coen Steven P.CIK 0001977441 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | Class A Common Stock | MOption exerciseAcquired | +587 | – | – | 50,855 | Direct | |
| May 21, 2026 | Class A Common Stock | MOption exerciseAcquired | +156 | – | – | 51,011 | Direct | |
| May 22, 2026 | Class A Common Stock | SSaleDisposed | −307 | $8.33 | −$2,557.31 | 50,704 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | Class A Common Stock | MOption exerciseDisposed | −587 | – | – | 7,057 | Direct | |
| May 21, 2026 | Class A Common Stock | MOption exerciseDisposed | −156 | – | – | 3,443 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.